Natural antioxidants in prevention and management of Alzheimer's disease

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 3, 2012, Pages 794-808

  Zhao, Yan ^a   Zhao, Baolu ^b  

^a HARBIN INSTITUTE OF TECHNOLOGY   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

Author keywords

Alzheimer's disease; Free radicals; Natural antioxidants; Neurodegenerative diseases; Oxidative stress; Review

Indexed keywords

4 HYDROXYNONENAL; FLAVONOID; GINKGO BILOBA EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOFLAVONE DERIVATIVE; ISOPROSTANE DERIVATIVE; MALONALDEHYDE; NICOTINE; PROTEIN BCL 2; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TERPENOID; THEANINE; UNCOUPLING PROTEIN; ANTIOXIDANT; BIOLOGICAL PRODUCT;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CHRONIC DISEASE; COGNITION; DOWN REGULATION; ENZYME ACTIVITY; ESTROGEN DEFICIENCY; GINKGO BILOBA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; NEUROPROTECTION; NONHUMAN; ONCOGENE C MYC; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; SOYBEAN; TRANSGENIC MOUSE; ANIMAL; METABOLISM; REVIEW; TRANSGENIC ANIMAL;

ANIMALIA; GINKGO BILOBA; GLYCINE MAX;

ALZHEIMER DISEASE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIOXIDANTS; BIOLOGICAL AGENTS; HUMANS; OXIDATIVE STRESS;

EID: 84858960854     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e419     Document Type: Article

References (169)

1. H. W. Querfurth and F. M. LaFerla: Alzheimer's disease. N Engl J Med 362, (4) 329-44 (2010)
2. 2010 Alzheimer's disease facts and figures. Alzheimers Dement 6, (2) 158-94 (2010)
3. M. J. Dong, B. Peng, X. T. Lin, J. Zhao, Y. R. Zhou, and R. H. Wang: The prevalence of dementia in the People's Republic of China: a systematic analysis of 1980-2004 studies. Age Ageing 36, (6) 619-24 (2007) (Pubitemid 350258969)
4. C. P. Ferri, M. Prince, C. Brayne, H. Brodaty, L. Fratiglioni, M. Ganguli, K. Hall, K. Hasegawa, H. Hendrie, Y. Huang, A. Jorm, C. Mathers, P. R. Menezes, E. Rimmer, and M. Scazufca: Global prevalence of dementia: a Delphi consensus study. Lancet 366, (9503) 2112-7 (2005) (Pubitemid 41797645)
5. R. N. Kalaria, G. E. Maestre, R. Arizaga, R. P. Friedland, D. Galasko, K. Hall, J. A. Luchsinger, A. Ogunniyi, E. K. Perry, F. Potocnik, M. Prince, R. Stewart, A. Wimo, Z. X. Zhang, and P. Antuono: Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol 7, (9) 812-26 (2008)
6. G. Wang, Q. Cheng, S. Zhang, L. Bai, J. Zeng, P. J. Cui, T. Zhang, Z. K. Sun, R. J. Ren, Y. L. Deng, W. Xu, Y. Wang, and S. D. Chen: Economic impact of dementia in developing countries: an evaluation of Alzheimer-type dementia in Shanghai, China. J Alzheimers Dis 15, (1) 109-15 (2008)
7. L. Jonsson and A. Wimo: The cost of dementia in Europe: a review of the evidence, and methodological considerations. Pharmacoeconomics 27, (5) 391-403 (2009)
8. A. Wimo, B. Winblad, and L. Jonsson: The worldwide societal costs of dementia: Estimates for 2009. Alzheimers Dement 6, (2) 98-103 (2010)
9. M. Goedert and M. G. Spillantini: A century of Alzheimer's disease. Science 314, (5800) 777-81 (2006) (Pubitemid 44706636)
10. H. Steiner: Uncovering gamma-secretase. Curr Alzheimer Res 1, (3) 175-81 (2004)
11. D. M. Walsh and D. J. Selkoe: A beta oligomers -A decade of discovery. J Neurochem 101, (5) 1172-84 (2007)
12. W. P. Esler and M. S. Wolfe: A portrait of Alzheimer secretases-new features and familiar faces. Science 293, (5534) 1449-54 (2001) (Pubitemid 32801541)
13. B. A. Yankner and T. Lu: Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease. J Biol Chem 284, (8) 4755-9 (2009)
14. E. D. Roberson and L. Mucke: 100 years and counting: prospects for defeating Alzheimer's disease. Science 314, (5800) 781-4 (2006) (Pubitemid 44706637)
15. R. B. Maccioni, J. P. Munoz, and L. Barbeito: The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch Med Res 32, (5) 367-81 (2001) (Pubitemid 32918139)
16. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole: Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, (5284) 99-102 (1996) (Pubitemid 26332733)
17. K. Iqbal, F. Liu, C. X. Gong, C. Alonso Adel, and I. Grundke-Iqbal: Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 118, (1) 53-69 (2009)
18. M. L. Billingsley and R. L. Kincaid: Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem J 323 ( Pt 3), 577-91 (1997) (Pubitemid 27202326)
19. N. Ghoshal, F. Garcia-Sierra, J. Wuu, S. Leurgans, D. A. Bennett, R. W. Berry, and L. I. Binder: Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp Neurol 177, (2) 475-93 (2002) (Pubitemid 35366136)
20. K. Santacruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K. H. Ashe: Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, (5733) 476-81 (2005) (Pubitemid 40994688)
21. S. Le Corre, H. W. Klafki, N. Plesnila, G. Hubinger, A. Obermeier, H. Sahagun, B. Monse, P. Seneci, J. Lewis, J. Eriksen, C. Zehr, M. Yue, E. McGowan, D. W. Dickson, M. Hutton, and H. M. Roder: An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice. Proc Natl Acad Sci U S A 103, (25) 9673-8 (2006) (Pubitemid 43955883)
22. W. H. Zheng, S. Bastianetto, F. Mennicken, W. Ma, and S. Kar: Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience 115, (1) 201-11 (2002) (Pubitemid 35232701)
23. J. Lewis, D. W. Dickson, W. L. Lin, L. Chisholm, A. Corral, G. Jones, S. H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton, and E. McGowan: Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, (5534) 1487-91 (2001) (Pubitemid 32801551)
24. J. Gotz, F. Chen, J. van Dorpe, and R. M. Nitsch: Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 293, (5534) 1491-5 (2001) (Pubitemid 32807681)
25. D. Pratico: Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Trends in Pharmacological Sciences 29, (12) 609-615 (2008)
26. E. R. Stadtman: Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic Biol Med 9, (4) 315-25 (1990) (Pubitemid 120036900)
27. , A. Nunomura, G. Perry, M. A. Pappolla, R. Wade, K. Hirai, S. Chiba, and M. A. Smith: RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 19, (6) 1959-64 (1999) (Pubitemid 29133374)
28. S. P. Gabbita, M. A. Lovell, and W. R. Markesbery: Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J Neurochem 71, (5) 2034-40 (1998) (Pubitemid 28491559)
29. P. Mecocci, U. MacGarvey, and M. F. Beal: Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 36, (5) 747-51 (1994) (Pubitemid 24337634)
30. D. A. Butterfield and J. Kanski: Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech Ageing Dev 122, (9) 945-62 (2001) (Pubitemid 32441616)
31. M. F. Beal: Oxidatively modified proteins in aging and disease. Free Radic Biol Med 32, (9) 797-803 (2002) (Pubitemid 34439250)
32. D. Pratico and S. Sung: Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J Alzheimers Dis 6, (2) 171-5 (2004) (Pubitemid 38560253)
33. M. A. Lovell, W. D. Ehmann, S. M. Butler, and W. R. Markesbery: Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45, (8) 1594-601 (1995)
34. W. R. Markesbery and M. A. Lovell: Fourhydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 19, (1) 33-6 (1998) (Pubitemid 28167792)
35. T. I. Williams, B. C. Lynn, W. R. Markesbery, and M. A. Lovell: Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiol Aging 27, (8) 1094-9 (2006) (Pubitemid 43850642)
36. D. L. Marcus, C. Thomas, C. Rodriguez, K. Simberkoff, J. S. Tsai, J. A. Strafaci, and M. L. Freedman: Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol 150, (1) 40-4 (1998) (Pubitemid 28146421)
37. M. Padurariu, A. Ciobica, L. Hritcu, B. Stoica, W. Bild, and C. Stefanescu: Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 469, (1) 6-10 (2010)
38. R. A. Omar, Y. J. Chyan, A. C. Andorn, B. Poeggeler, N. K. Robakis, and M. A. Pappolla: Increased Expression but Reduced Activity of Antioxidant Enzymes in Alzheimer's Disease. J Alzheimers Dis 1, (3) 139-145 (1999)
39. A. Furuta, D. L. Price, C. A. Pardo, J. C. Troncoso, Z. S. Xu, N. Taniguchi, and L. J. Martin: Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. Am J Pathol 146, (2) 357-67 (1995)
40. M. A. Ansari and S. W. Scheff: Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol 69, (2) 155-67 (2010)
41. M. A. Smith, C. A. Rottkamp, A. Nunomura, A. K. Raina, and G. Perry: Oxidative stress in Alzheimer's disease. Biochim Biophys Acta 1502, (1) 139-44 (2000) (Pubitemid 30433863)
42. S. Varadarajan, S. Yatin, M. Aksenova, and D. A. Butterfield: Review: Alzheimer's amyloid beta-peptideassociated free radical oxidative stress and neurotoxicity. J Struct Biol 130, (2-3) 184-208 (2000)
43. M. P. Mattson: Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 77, (4) 1081-132 (1997) (Pubitemid 27459580)
44. C. Behl, J. B. Davis, R. Lesley, and D. Schubert: Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77, (6) 817-27 (1994) (Pubitemid 24187680)
45. Y. Matsuoka, M. Picciano, J. La Francois, and K. Duff: Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease. Neuroscience 104, (3) 609-13 (2001) (Pubitemid 32607413)
46. M. A. Smith, K. Hirai, K. Hsiao, M. A. Pappolla, P. L. Harris, S. L. Siedlak, M. Tabaton, and G. Perry: Amyloidbeta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 70, (5) 2212-5 (1998) (Pubitemid 28207848)
47. H. Mohmmad Abdul, R. Sultana, J. N. Keller, D. K. St Clair, W. R. Markesbery, and D. A. Butterfield: Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease. J Neurochem 96, (5) 1322-35 (2006)
48. M. Manczak, T. S. Anekonda, E. Henson, B. S. Park, J. Quinn, and P. H. Reddy: Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15, (9) 1437-49 (2006)
49. J. Apelt, M. Bigl, P. Wunderlich, and R. Schliebs: Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and betaamyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology. Int J Dev Neurosci 22, (7) 475-84 (2004) (Pubitemid 39311436)
50. F. G. De Felice, P. T. Velasco, M. P. Lambert, K. Viola, S. J. Fernandez, S. T. Ferreira, and W. L. Klein: Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282, (15) 11590-601 (2007) (Pubitemid 47100810)
51. C. Caspersen, N. Wang, J. Yao, A. Sosunov, X. Chen, J. W. Lustbader, H. W. Xu, D. Stern, G. McKhann, and S. D. Yan: Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. Faseb J 19, (14) 2040-1 (2005) (Pubitemid 41759758)
52. S. Tan, Y. Sagara, Y. Liu, P. Maher, and D. Schubert: The regulation of reactive oxygen species production during programmed cell death. J Cell Biol 141, (6) 1423-32 (1998) (Pubitemid 28289917)
53. V. G. Grivennikova and A. D. Vinogradov: Generation of superoxide by the mitochondrial Complex I. Biochim Biophys Acta 1757, (5-6) 553-61 (2006) (Pubitemid 43993849)
54. C. M. Rodrigues, S. Sola, M. A. Brito, C. D. Brondino, D. Brites, and J. J. Moura: Amyloid beta-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate. Biochem Biophys Res Commun 281, (2) 468-74 (2001) (Pubitemid 32928179)
55. C. S. Casley, L. Canevari, J. M. Land, J. B. Clark, and M. A. Sharpe: Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J Neurochem 80, (1) 91-100 (2002) (Pubitemid 34614581)
56. M. Anantharaman, J. Tangpong, J. N. Keller, M. P. Murphy, W. R. Markesbery, K. K. Kiningham, and D. K. St Clair: Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease. Am J Pathol 168, (5) 1608-18 (2006)
57. S. Rousset, M. C. Alves-Guerra, J. Mozo, B. Miroux, A. M. Cassard-Doulcier, F. Bouillaud, and D. Ricquier: The biology of mitochondrial uncoupling proteins. Diabetes 53 Suppl 1, S130-5 (2004) (Pubitemid 38168705)
58. K. S. Echtay: Mitochondrial uncoupling proteins-what is their physiological role? Free Radic Biol Med 43, (10) 1351-71 (2007) (Pubitemid 47532367)
59. S. M. de la Monte and J. R. Wands: Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease. J Alzheimers Dis 9, (2) 167-81 (2006) (Pubitemid 44088244)
60. Z. Wu, J. Zhang, and B. Zhao: Superoxide anion regulates the mitochondrial free Ca2+ through uncoupling proteins. Antioxid Redox Signal 11, (8) 1805-18 (2009)
61. F. Li, N. Y. Calingasan, F. Yu, W. M. Mauck, M. Toidze, C. G. Almeida, R. H. Takahashi, G. A. Carlson, M. Flint Beal, M. T. Lin, and G. K. Gouras: Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J Neurochem 89, (5) 1308-12 (2004) (Pubitemid 38715849)
62. Y. Nishida, T. Yokota, T. Takahashi, T. Uchihara, K. Jishage, and H. Mizusawa: Deletion of vitamin E enhances phenotype of Alzheimer disease model mouse. Biochem Biophys Res Commun 350, (3) 530-6 (2006) (Pubitemid 44547880)
63. G. P. Lim, T. Chu, F. Yang, W. Beech, S. A. Frautschy, and G. M. Cole: The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21, (21) 8370-7 (2001) (Pubitemid 33051435)
64. M. Dumont, E. Wille, C. Stack, N. Y. Calingasan, M. F. Beal, and M. T. Lin: Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. Faseb J 23, (8) 2459-66 (2009)
65. E. Tamagno, P. Bardini, A. Obbili, A. Vitali, R. Borghi, D. Zaccheo, M. A. Pronzato, O. Danni, M. A. Smith, G. Perry, and M. Tabaton: Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol Dis 10, (3) 279-88 (2002) (Pubitemid 35217581)
66. A. Oda, A. Tamaoka, and W. Araki: Oxidative stress up-regulates presenilin 1 in lipid rafts in neuronal cells. J Neurosci Res 88, (5) 1137-45 (2009)
67. M. H. Yoo, X. Gu, X. M. Xu, J. Y. Kim, B. A. Carlson, A. D. Patterson, H. Cai, V. N. Gladyshev, and D. L. Hatfield: Delineating the role of glutathione peroxidase 4 in protecting cells against lipid hydroperoxide damage and in Alzheimer's disease. Antioxid Redox Signal 12, (7) 819-27 (2010)
68. L. Chen, R. Na, M. Gu, A. Richardson, and Q. Ran: Lipid peroxidation up-regulates BACE1 expression in vivo: a possible early event of amyloidogenesis in Alzheimer's disease. J Neurochem 107, (1) 197-207 (2008)
69. E. Tamagno, M. Guglielmotto, M. Aragno, R. Borghi, R. Autelli, L. Giliberto, G. Muraca, O. Danni, X. Zhu, M. A. Smith, G. Perry, D. G. Jo, M. P. Mattson, and M. Tabaton: Oxidative stress activates a positive feedback between the gamma-and beta-secretase cleavages of the beta-amyloid precursor protein. J Neurochem 104, (3) 683-95 (2008)
70. C. Shen, Y. Chen, H. Liu, K. Zhang, T. Zhang, A. Lin, and N. Jing: Hydrogen peroxide promotes Abeta production through JNK-dependent activation of gamma-secretase. J Biol Chem 283, (25) 17721-30 (2008)
71. K. Sambamurti, R. Kinsey, B. Maloney, Y. W. Ge, and D. K. Lahiri: Gene structure and organization of the human betasecretase (BACE) promoter. Faseb J 18, (9) 1034-6 (2004) (Pubitemid 39561516)
72. X. Zhu, A. K. Raina, C. A. Rottkamp, G. Aliev, G. Perry, H. Boux, and M. A. Smith: Activation and redistribution of cjun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J Neurochem 76, (2) 435-41 (2001) (Pubitemid 32097021)
73. X. Zhu, O. Ogawa, Y. Wang, G. Perry, and M. A. Smith: JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease. J Neurochem 85, (1) 87-93 (2003) (Pubitemid 36389698)
74. S. Lagalwar, A. L. Guillozet-Bongaarts, R. W. Berry, and L. I. Binder: Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease. J Neuropathol Exp Neurol 65, (5) 455-64 (2006) (Pubitemid 44297267)
75. H. Fukumoto, B. S. Cheung, B. T. Hyman, and M. C. Irizarry: Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol 59, (9) 1381-9 (2002) (Pubitemid 35014802)
76. L. B. Yang, K. Lindholm, R. Yan, M. Citron, W. Xia, X. L. Yang, T. Beach, L. Sue, P. Wong, D. Price, R. Li, and Y. Shen: Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 9, (1) 3-4 (2003) (Pubitemid 36098241)
77. T. Matsui, M. Ingelsson, H. Fukumoto, K. Ramasamy, H. Kowa, M. P. Frosch, M. C. Irizarry, and B. T. Hyman: Expression of APP pathway mRNAs and proteins in Alzheimer's disease. Brain Res 1161, 116-23 (2007) (Pubitemid 47068429)
78. M. Yao, T. V. Nguyen, and C. J. Pike: Beta-amyloidinduced neuronal apoptosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w. J Neurosci 25, (5) 1149-58 (2005) (Pubitemid 40268956)
79. A. Lleo, S. M. Greenberg, and J. H. Growdon: Current pharmacotherapy for Alzheimer's disease. Annu Rev Med 57, 513-33 (2006) (Pubitemid 43262005)
80. C. P. Ward, K. Redd, B. M. Williams, J. R. Caler, Y. Luo, and J. G. McCoy: Ginkgo biloba extract: cognitive enhancer or antistress buffer. Pharmacol Biochem Behav 72, (4) 913-22 (2002) (Pubitemid 34621318)
81. P. Curtis-Prior, D. Vere, and P. Fray: Therapeutic value of Ginkgo biloba in reducing symptoms of decline in mental function. J Pharm Pharmacol 51, (5) 535-41 (1999) (Pubitemid 29319778)
82. E. Winter: Effects of an extract of Ginkgo biloba on learning and memory in mice. Pharmacol Biochem Behav 38, (1) 109-14 (1991)
83. J. C. Winter: The effects of an extract of Ginkgo biloba, EGb 761, on cognitive behavior and longevity in the rat. Physiol Behav 63, (3) 425-33 (1998) (Pubitemid 28055574)
84. Y. Ni, B. Zhao, J. Hou, and W. Xin: Preventive effect of Ginkgo biloba extract on apoptosis in rat cerebellar neuronal cells induced by hydroxyl radicals. Neurosci Lett 214, (2-3) 115-8 (1996) (Pubitemid 26284445)
85. T. Wei, Y. Ni, J. Hou, C. Chen, B. Zhao, and W. Xin: Hydrogen peroxide-induced oxidative damage and apoptosis in cerebellar granule cells: protection by Ginkgo biloba extract. Pharmacol Res 41, (4) 427-33 (2000)
86. W. Xin, T. Wei, C. Chen, Y. Ni, B. Zhao, and J. Hou: Mechanisms of apoptosis in rat cerebellar granule cells induced by hydroxyl radicals and the effects of EGb761 and its constituents. Toxicology 148, (2-3) 103-10 (2000) (Pubitemid 30621349)
87. C. Chen, T. Wei, Z. Gao, B. Zhao, J. Hou, H. Xu, W. Xin, and L. Packer: Different effects of the constituents of EGb761 on apoptosis in rat cerebellar granule cells induced by hydroxyl radicals. Biochem Mol Biol Int 47, (3) 397-405 (1999) (Pubitemid 29155075)
88. S. Bastianetto, W. H. Zheng, and R. Quirion: The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C. J Neurochem 74, (6) 2268-77 (2000) (Pubitemid 30314201)
89. S. Bastianetto, C. Ramassamy, S. Dore, Y. Christen, J. Poirier, and R. Quirion: The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid. Eur J Neurosci 12, (6) 1882-90 (2000) (Pubitemid 30348827)
90. K. Ishige, D. Schubert, and Y. Sagara: Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med 30, (4) 433-46 (2001) (Pubitemid 32155542)
91. G. Rimbach, K. Gohil, S. Matsugo, H. Moini, C. Saliou, F. Virgili, S. U. Weber, and L. Packer: Induction of glutathione synthesis in human keratinocytes by Ginkgo biloba extract (EGb761). Biofactors 15, (1) 39-52 (2001) (Pubitemid 34014663)
92. Y. Luo, J. V. Smith, V. Paramasivam, A. Burdick, K. J. Curry, J. P. Buford, I. Khan, W. J. Netzer, H. Xu, and P. Butko: Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci U S A 99, (19) 12197-202 (2002)
93. J. V. Smith, A. J. Burdick, P. Golik, I. Khan, D. Wallace, and Y. Luo: Anti-apoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells. Cell Mol Biol (Noisy-legrand) 48, (6) 699-707 (2002)
94. J. V. Smith and Y. Luo: Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. J Alzheimers Dis 5, (4) 287-300 (2003) (Pubitemid 37411776)
95. Y. Wu, Z. Wu, P. Butko, Y. Christen, M. P. Lambert, W. L. Klein, C. D. Link, and Y. Luo: Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J Neurosci 26, (50) 13102-13 (2006) (Pubitemid 44954628)
96. F. Tchantchou, Y. Xu, Y. Wu, Y. Christen, and Y. Luo: EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer's disease. Faseb J 21, (10) 2400-8 (2007) (Pubitemid 47230670)
97. R. W. Stackman, F. Eckenstein, B. Frei, D. Kulhanek, J. Nowlin, and J. F. Quinn: Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment. Exp Neurol 184, (1) 510-20 (2003) (Pubitemid 37444058)
98. J. F. Quinn, J. R. Bussiere, R. S. Hammond, T. J. Montine, E. Henson, R. E. Jones and R. W. Stackman,: Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice. Neurobiol Aging 28, 213-225 (2007) (Pubitemid 44894634)
99. T. Yoshitake, S. Yoshitake, and J. Kehr: The Ginkgo biloba extract EGb 761(R) and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex. Br J Pharmacol 159, 659-668 (2010)
100. B. S. Oken, D. M. Storzbach, and J. A. Kaye: The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 55, (11) 1409-15 (1998) (Pubitemid 28525500)
101. P. L. Le Bars, M. Kieser, and K. Z. Itil: A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia. Dement Geriatr Cogn Disord 11, (4) 230-7 (2000) (Pubitemid 30416029)
102. P. L. Le Bars, M. M. Katz, N. Berman, T. M. Itil, A. M. Freedman, and A. F. Schatzberg: A placebocontrolled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. Jama 278, (16) 1327-32 (1997) (Pubitemid 27449692)
103. J. A. Mix and W. D. Crews, Jr.: A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings. Hum Psychopharmacol 17, (6) 267-77 (2002)
104. S. Kanowski and R. Hoerr: Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. Pharmacopsychiatry 36, (6) 297-303 (2003) (Pubitemid 38085148)
105. B. E. Snitz, E. S. O'Meara, M. C. Carlson, A. M. Arnold, D. G. Ives, S. R. Rapp, J. Saxton, O. L. Lopez, L. O. Dunn, K. M. Sink, and S. T. DeKosky: Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. Jama 302, (24) 2663-70 (2009)
106. S. T. DeKosky, J. D. Williamson, A. L. Fitzpatrick, R. A. Kronmal, D. G. Ives, J. A. Saxton, O. L. Lopez, G. Burke, M. C. Carlson, L. P. Fried, L. H. Kuller, J. A. Robbins, R. P. Tracy, N. F. Woolard, L. Dunn, B. E. Snitz, R. L. Nahin, and C. D. Furberg: Ginkgo biloba for prevention of dementia: a randomized controlled trial. Jama 300, (19) 2253-62 (2008)
107. R. Li and Y. Shen: Estrogen and brain: synthesis, function and diseases. Front Biosci 10, 257-67 (2005) (Pubitemid 40543032)
108. C. Behl, T. Skutella, F. Lezoualc'h, A. Post, M. Widmann, C. J. Newton, and F. Holsboer: Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 51, (4) 535-41 (1997) (Pubitemid 27172978)
109. S. Gandy: Estrogen and neurodegeneration. Neurochem Res 28, (7) 1003-8 (2003) (Pubitemid 36581850)
110. R. F. Zec and M. A. Trivedi: The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review. Neuropsychol Rev 12, (2) 65-109 (2002) (Pubitemid 38429536)
111. P. A. Murphy, E. Farmakalidis, and L. D. Johnson: Isoflavone content of soya-based laboratory animal diets. Food Chem Toxicol 20, (3) 315-7 (1982)
112. M. S. Kurzer and X. Xu: Dietary phytoestrogens. Annu Rev Nutr 17, 353-81 (1997) (Pubitemid 27328805)
113. Q. Guo, G. Rimbach, H. Moini, S. Weber, and L. Packer: ESR and cell culture studies on free radicalscavenging and antioxidant activities of isoflavonoids. Toxicology 179, (1-2) 171-80 (2002) (Pubitemid 35245473)
114. W. H. Chan and J. S. Yu: Inhibition of UV irradiationinduced oxidative stress and apoptotic biochemical changes in human epidermal carcinoma A431 cells by genistein. J Cell Biochem 78, (1) 73-84 (2000)
115. T. Ohigashi, M. Ueno, S. Nonaka, T. Nakanoma, Y. Furukawa, N. Deguchi, and M. Murai: Tyrosine kinase inhibitors reduce bcl-2 expression and induce apoptosis in androgen-dependent cells. Am J Physiol Cell Physiol 278, (1) C66-72 (2000) (Pubitemid 30101896)
116. H. Kim, H. Xia, L. Li, and J. Gewin: Attenuation of neurodegeneration- relevant modifications of brain proteins by dietary soy. Biofactors 12, (1-4) 243-50 (2000) (Pubitemid 32107412)
117. K. L. Johnson, F. Vaillant, and A. Lawen: Protein tyrosine kinase inhibitors prevent didemnin B-induced apoptosis in HL-60 cells. FEBS Lett 383, (1-2) 1-5 (1996) (Pubitemid 26093715)
118. T. B. Clarkson, M. S. Anthony, J. K. Williams, E. K. Honore, and J. M. Cline: The potential of soybean phytoestrogens for postmenopausal hormone replacement therapy. Proc Soc Exp Biol Med 217, (3) 365-8 (1998)
119. C. A. Lamartiniere, J. X. Zhang, and M. S. Cotroneo: Genistein studies in rats: potential for breast cancer prevention and reproductive and developmental toxicity. Am J Clin Nutr 68, (6 Suppl) 1400S-1405S (1998) (Pubitemid 28550920)
120. J. M. Andersen, O. Myhre, and F. Fonnum: Discussion of the role of the extracellular signal-regulated kinasephospholipase A2 pathway in production of reactive oxygen species in Alzheimer's disease. Neurochem Res 28, (2) 319-26 (2003) (Pubitemid 36207355)
121. S. L. Valles, C. Borras, J. Gambini, J. Furriol, A. Ortega, J. Sastre, F. V. Pallardo, and J. Vina: Oestradiol or genistein rescues neurons from amyloid beta-induced cell death by inhibiting activation of p38. Aging Cell 7, (1) 112-8 (2008) (Pubitemid 351144607)
122. H. Zeng, Q. Chen, and B. Zhao: Genistein ameliorates beta-amyloid peptide (25-35)-induced hippocampal neuronal apoptosis. Free Radic Biol Med 36, (2) 180-8 (2004) (Pubitemid 38117236)
123. J. A. Hartigan and G. V. Johnson: Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase 3beta-dependent pathway. J Biol Chem 274, (30) 21395-401 (1999)
124. A. Gutierrez-Zepeda, R. Santell, Z. Wu, M. Brown, Y. Wu, I. Khan, C. D. Link, B. Zhao, and Y. Luo: Soy isoflavone glycitein protects against beta amyloid-induced toxicity and oxidative stress in transgenic Caenorhabditis elegans. BMC Neurosci 6, 54 (2005)
125. L. Zhao and R. D. Brinton: WHI and WHIMS followup and human studies of soy isoflavones on cognition. Expert Rev Neurother 7, (11) 1549-64 (2007)
126. S. A. Kaiser and S. Wonnacott, Nicotic receptor modulation of neurotransmitter release, in Neuronal nicotinic receptors: pharmacology and therapeutic opportunities. S. P. Arneric and J. D. Brioni, Editors Wiley-Liss Inc, New York (1999)
127. Q. Liu, Y. Tao, and B. Zhao: ESR study on scavenging effect of nicotine on free radicals. Applied Magnetic Resonance 24, (1) 105-112 (2003) (Pubitemid 37386740)
128. Q. Liu and B. Zhao: Nicotine attenuates beta-amyloid peptide-induced neurotoxicity, free radical and calcium accumulation in hippocampal neuronal cultures. Br J Pharmacol 141, (4) 746-54 (2004) (Pubitemid 38453267)
129. Y. X. Xie, E. Bezard, and B. L. Zhao: Investigating the receptor-independent neuroprotective mechanisms of nicotine in mitochondria. J Biol Chem 280, (37) 32405-12 (2005) (Pubitemid 41361851)
130. A. Nordberg, E. Hellstrom-Lindahl, M. Lee, M. Johnson, M. Mousavi, R. Hall, E. Perry, I. Bednar, and J. Court: Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw). J Neurochem 81, (3) 655-8 (2002) (Pubitemid 34809344)
131. E. Hellstrom-Lindahl, H. Moore, and A. Nordberg: Increased levels of tau protein in SH-SY5Y cells after treatment with cholinesterase inhibitors and nicotinic agonists. J Neurochem 74, (2) 777-84 (2000) (Pubitemid 30053751)
132. Q. Liu, J. Zhang, H. Zhu, C. Qin, Q. Chen, and B. Zhao: Dissecting the signaling pathway of nicotinemediated neuroprotection in a mouse Alzheimer disease model. Faseb J 21, (1) 61-73 (2007) (Pubitemid 46052545)
133. M. A. Lovell, J. D. Robertson, W. J. Teesdale, J. L. Campbell, and W. R. Markesbery: Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158, (1) 47-52 (1998) (Pubitemid 28277534)
134. D. Strausak, J. F. Mercer, H. H. Dieter, W. Stremmel, and G. Multhaup: Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases. Brain Res Bull 55, (2) 175-85 (2001) (Pubitemid 32722157)
135. C. S. Atwood, R. D. Moir, X. Huang, R. C. Scarpa, N. M. Bacarra, D. M. Romano, M. A. Hartshorn, R. E. Tanzi, and A. I. Bush: Dramatic aggregation of Alzheimer abeta by Cu (II) is induced by conditions representing physiological acidosis. J Biol Chem 273, (21) 12817-26 (1998) (Pubitemid 28246837)
136. L. Hesse, D. Beher, C. L. Masters, and G. Multhaup: The beta A4 amyloid precursor protein binding to copper. FEBS Lett 349, (1) 109-16 (1994)
137. A. I. Bush: Metal complexing agents as therapies for Alzheimer's disease. Neurobiol Aging 23, (6) 1031-8 (2002) (Pubitemid 35447784)
138. A. I. Bush, W. H. Pettingell, G. Multhaup, M. d Paradis, J. P. Vonsattel, J. F. Gusella, K. Beyreuther, C. L. Masters, and R. E. Tanzi: Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 265, (5177) 1464-7 (1994) (Pubitemid 24306803)
139. J. Zhang, Q. Liu, Q. Chen, N. Q. Liu, F. L. Li, Z. B. Lu, C. Qin, H. Zhu, Y. Y. Huang, W. He and B. L. Zhao: Nicotine attenuates beta-amyloid-induced neurotoxicity by regulating metal homeostasis. Faseb J 20, (8) 1212-4 (2006)
140. M. Srivareerat, T. T. Tran, S. Salim, A. M. Aleisa and Alkadhi, K. A: Chronic nicotine restores normal Abeta levels and prevents short-term memory and E-LTP impairment in Abeta rat model of Alzheimer's disease. Neurobiol Aging (Epub ahead of print, 2009 May 20)
141. A. Finger, S. Kuhr, and U. H. Engelhardt: Chromatography of tea constituents. J Chromatogr 624, (1-2) 293-315 (1992) (Pubitemid 23008616)
142. J. Bryan: Psychological effects of dietary components of tea: caffeine and L-Theanine. Nutr Rev 66, (2) 82-90 (2008) (Pubitemid 351666653)
143. T. Kakuda, A. Nozawa, A. Sugimoto, and H. Niino: Inhibition by theanine of binding of (3H)AMPA, (3H)kainate, and (3H)MDL 105,519 to glutamate receptors. Biosci Biotechnol Biochem 66, (12) 2683-6 (2002) (Pubitemid 39251144)
144. S. Lesne, C. Ali, C. Gabriel, N. Croci, E. T. MacKenzie, C. G. Glabe, M. Plotkine, C. Marchand-Verrecchia, D. Vivien, and A. Buisson: NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production. J Neurosci 25, (41) 9367-77 (2005) (Pubitemid 41464749)
145. K. Parameshwaran, M. Dhanasekaran, and V. Suppiramaniam: Amyloid beta peptides and glutamatergic synaptic dysregulation. Exp Neurol 210, (1) 7-13 (2008) (Pubitemid 351258072)
146. X. Di, J. Yan, Y. Zhao, J. Zhang, Z. Shi, Y. Chang, and B. Zhao: L-Theanine protects the APP (Swedish mutation) transgenic SH-SY5Y cell against glutamateinduced excitotoxicity via inhibition of the NMDA receptor pathway. Neuroscience 168, (3) 778-86 (2010)
147. M. R. Hynd, H. L. Scott, and P. R. Dodd: Glutamatemediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int 45, (5) 583-95 (2004) (Pubitemid 38844879)
148. T. I. Kim, Y. K. Lee, S. G. Park, I. S. Choi, J. O. Ban, H. K. Park, S. Y. Nam, Y. W. Yun, S. B. Han, K. W. Oh and J. T. Hong: l-Theanine, an amino acid in green tea, attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kappaB pathways. Free Radic Biol Med 47, 1601-1610 (2009)
149. J. Zhang, A. Mori, Q. Chen, and B. Zhao: Fermented papaya preparation attenuates beta-amyloid precursor protein: beta-amyloid-mediated copper neurotoxicity in beta-amyloid precursor protein and beta-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells. Neuroscience 143, (1) 63-72 (2006) (Pubitemid 44667306)
150. Y. H. Wang and G. H. Du: Ginsenoside Rg1 inhibits beta-secretase activity in vitro and protects against Abetainduced cytotoxicity in PC12 cells. J Asian Nat Prod Res 11, (7) 604-12 (2009)
151. D. Butterfield, A. Castegna, C. Pocernich, J. Drake, G. Scapagnini, and V. Calabrese: Nutritional approaches to combat oxidative stress in Alzheimer's disease. J Nutr Biochem 13, (8) 444 (2002)
152. G. M. Cole, B. Teter, and S. A. Frautschy: Neuroprotective effects of curcumin. Adv Exp Med Biol 595, 197-212 (2007)
153. K. Bala, B. C. Tripathy, and D. Sharma: Neuroprotective and anti-ageing effects of curcumin in aged rat brain regions. Biogerontology 7, (2) 81-9 (2006) (Pubitemid 43950778)
154. S. A. Mandel, T. Amit, L. Kalfon, L. Reznichenko, and M. B. Youdim: Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins. J Nutr 138, (8) 1578S-1583S (2008)
155. K. Rezai-Zadeh, D. Shytle, N. Sun, T. Mori, H. Hou, D. Jeanniton, J. Ehrhart, K. Townsend, J. Zeng, D. Morgan, J. Hardy, T. Town, and J. Tan: Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 25, (38) 8807-14 (2005) (Pubitemid 41362059)
156. B. Giunta, H. Hou, Y. Zhu, J. Salemi, A. Ruscin, R. D. Shytle, and J. Tan: Fish oil enhances anti-amyloidogenic properties of green tea EGCG in Tg2576 mice. Neurosci Lett 471, (3) 134-8 (2010)
157. L. A. Horrocks and A. A. Farooqui: Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function. Prostaglandins Leukot Essent Fatty Acids 70, (4) 361-72 (2004) (Pubitemid 38429269)
158. M. C. Morris, D. A. Evans, J. L. Bienias, C. C. Tangney, D. A. Bennett, R. S. Wilson, N. Aggarwal, and J. Schneider: Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 60, (7) 940-6 (2003) (Pubitemid 36858352)
159. E. J. Schaefer, V. Bongard, A. S. Beiser, S. Lamon-Fava, S. J. Robins, R. Au, K. L. Tucker, D. J. Kyle, P. W. Wilson, and P. A. Wolf: Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol 63, (11) 1545-50 (2006) (Pubitemid 44748796)
160. Y. Freund-Levi, M. Eriksdotter-Jonhagen, T. Cederholm, H. Basun, G. Faxen-Irving, A. Garlind, I. Vedin, B. Vessby, L. O. Wahlund, and J. Palmblad: Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol 63, (10) 1402-8 (2006) (Pubitemid 44547551)
161. K. N. Green, H. Martinez-Coria, H. Khashwji, E. B. Hall, K. A. Yurko-Mauro, L. Ellis, and F. M. LaFerla: Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci 27, (16) 4385-95 (2007) (Pubitemid 46640724)
162. F. Calon, G. P. Lim, T. Morihara, F. Yang, O. Ubeda, N. Salem, S. A. Frautschy, and G. M. Cole: Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease. Eur J Neurosci 22, (3) 617-26 (2005) (Pubitemid 41192272)
163. G. P. Lim, F. Calon, T. Morihara, F. Yang, B. Teter, O. Ubeda, N. Salem, S. A. Frautschy, and G. M. Cole: A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 25, (12) 3032-40 (2005) (Pubitemid 40463537)
164. F. Calon, G. P. Lim, F. Yang, T. Morihara, B. Teter, O. Ubeda, P. Rostaing, A. Triller, N. Salem, K. H. Ashe, S. A. Frautschy, and G. M. Cole: Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43, (5) 633-45 (2004) (Pubitemid 39179724)
165. G. A. Jicha and W. R. Markesbery: Omega-3 fatty acids: potential role in the management of early Alzheimer's disease. Clin Interv Aging 5, 45-61 (2010)
166. W. J. Lukiw and N. G. Bazan: Docosahexaenoic acid and the aging brain. J Nutr 138, (12) 2510-4 (2008)
167. W. J. Lukiw, J. G. Cui, V. L. Marcheselli, M. Bodker, A. Botkjaer, K. Gotlinger, C. N. Serhan, and N. G. Bazan: A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 115, (10) 2774-83 (2005) (Pubitemid 41434404)
168. M. S. Hossain, M. Hashimoto, S. Gamoh, and S. Masumura: Antioxidative effects of docosahexaenoic acid in the cerebrum versus cerebellum and brainstem of aged hypercholesterolemic rats. J Neurochem 72, (3) 1133-8 (1999) (Pubitemid 29085028)
169. W. Komatsu, K. Ishihara, M. Murata, H. Saito, and K. Shinohara: Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress. Free Radic Biol Med 34, (8) 1006-16 (2003) (Pubitemid 36398560)